Welcome!

News Feed Item

Cardiovascular Surgical Devices: Technologies and Global Markets

LONDON, Sept. 2, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

Cardiovascular Surgical Devices: Technologies and Global Markets

https://www.reportbuyer.com/product/1863184/Cardiovascular-Surgical-Devices-Technologies-and-Global-Markets.html

STUDY GOALS AND OBJECTIVES

The goals of this study are to explore the different factors affecting cardiovascular surgery and the manufacture of cardiovascular devices, as well as to quantify the market for various segments of the cardiovascular device market. Cardiac surgery is increasing globally, with the contribution of macroeconomic factors such as aging populations, increasing rates of obesity, poor nutrition and other health stressors. In recent years, new technologies have been developed that make sophisticated therapies accessible for patients in previously underserved locations.

Whether through disease, congenital defects or degradation of cardiac and vascular function with advancing age, the incidence of cardiovascular disease is growing dramatically, substantiating the continued growth in cardiovascular surgical procedures.

REASONS FOR DOING THIS STUDY

The American Heart Association, in its publication Heart Disease and Stroke Statistics, 2013 Update At-A-Glance, estimates that 83.6 million American adults, or more than one in three, have one or more types of cardiovascular disease. Surgery represents the most effective therapy for certain advanced cardiovascular conditions. Recent innovations such as minimally invasive procedures, "beating heart" surgeries, ventricular assist devices and artificial hearts, replacement valves and treatments for hypertension such as renal denervation offer therapeutic options that result in shorter recovery times and reduced complication risks.

Newer cardiovascular devices and therapeutic techniques will play an increasing role in enhancing quality of life for a growing elderly population, as well as patient groups with poor cardiac function. The ability of government-run health agencies and private insurance providers to cope with the increased need for cardiovascular procedures, together with rising healthcare costs, have led agencies and insurers to closely evaluate their coverage for cardiovascular surgical procedures and continually seek out lower cost but still efficacious options.

This report will identify areas of growth within the cardiovascular surgical device market and will discuss innovative technologies that have been recently launched or are presently under development. Market growth rates will be projected based on manufacturers' net revenues, unless otherwise indicated.

This report is designed to achieve the following objectives:
• To describe the trends and developments affecting each type of cardiovascular surgical technology and discuss how each addresses market needs.
• To analyze market demand, competitive dynamics and regulatory/ reimbursement-related factors to project the market size for each technology and to highlight target applications.
• To examine the competitors in the cardiovascular surgical device business with respect to market position and product development.

This report is designed to appeal to many types of readers, including marketing and management executives within the medical device industry, venture capital professionals interested in exploring commercialization opportunities and anyone else who would like to better understand how market factors and technologies interact in this industry.

SCOPE OF REPORT

The scope of this study encompasses multiple technologies and procedures related to cardiovascular surgical devices. The study focused primarily on four categories of cardiovascular surgery: traditional (open), interventional, cardiac rhythm management (CRM) and cardiac ablation procedures. These procedure categories are categorized logically so that comparisons can be made within procedural groups as well as across the cardiovascular surgical devices industry as a whole. Note that carotid artery surgery related to stroke, AAA surgery to correct aortic aneurysms, and surgical and stenting procedures designed to address peripheral vascular disease are not addressed in detail in this report.
BCC analyzes the industry on a worldwide basis from market, product and technology perspectives. Regulations and reimbursement issues and patents issued from 2010 through mid-2013 are also examined to identify patient safety, regulatory review and insurance coverage issues for stakeholders and potential stakeholders in this industry.

The report examines the cardiovascular surgery device industry in general, the types of technologies currently in use as well as future technological developments, and regulatory influences that affect product distribution. The industry structure section discussed the most active manufactures with respect to relative market share, marketing strengths and forces that promote or hinder the growth of technologies. The technology sections detail historical, current (2013) and projected (2013 to 2018) market values.

METHODOLOGY

BCC presents an analysis across the entire cardiovascular surgical device market based on company-specific revenue dollars and units shipped as reported to the U.S. Securities and Exchange Commission (SEC) and/or other governmental agencies, as well as company information such as conversations with company officials, annual reports and product/financial news releases.

We also analyze data collected from the United States Patent Office (USPTO) databases. Technological and demographic information is gathered from industry sources, governmental sources and published news reports.

INFORMATION SOURCES

BCC conducted primary and secondary research to develop this report. Sources included companies in the cardiovascular device market and supply industry, public documents, SEC filings, corporate white papers and other technical documentation for U.S. and international companies directly involved in manufacturing and distributing of cardiovascular surgery devices and related products. The report excludes resellers and retailers, focusing rather on the primary companies responsible for the development of the underlying technology. Where precise information was not available, a consensus was made using reasonable assumptions and estimates based on historical data.

ANALYST CREDENTIALS

Mary C. Patton, M.B.A, D.B.A., is the BCC Research Analyst of this report. Dr. Patton's experience includes over 25 years of designing and managing custom research projects involving both qualitative and quantitative techniques with a broad range of medical, surgical and healthcare industry providers and patients. She has conducted extensive research on surgical devices, diagnostic equipment, specific disease states, EMR systems and PACS systems. She has also worked in product management and strategic management roles for several major medical device manufacturers. Dr. Patton is the author of more than a dozen previous research reports related to the medical device industry.

REPORT HIGHLIGHTS

This report provides:
• An overview of the global market for cardiovascular surgical devices.
• Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) for the period 2013 to 2018.
• Incidence rates of cardiovascular diseases in the United States, WHO regions, and in selected countries.
• Discussion of key cardiovascular surgical procedures, traditional and interventional surgery, and adoption of robotics in surgery.
• Examination of procedures related to cardiac rhythm management, including devices and definitions.
• Reviews of procedures and devices related to cardiac assist.
• Patent analysis of various devices by year and by assignee.
• Comprehensive company profiles of major players in the industry.
TABLE OF CONTENTS

CHAPTER 1 INTRODUCTION 2

STUDY GOALS AND OBJECTIVES 2
REASONS FOR DOING THIS STUDY 2
SCOPE OF REPORT 3
METHODOLOGY 3
INFORMATION SOURCES 4
ANALYST CREDENTIALS 4
RELATED BCC PUBLICATIONS 4
BCC ONLINE SERVICES 4
DISCLAIMER 5

CHAPTER 2 SUMMARY 7

SUMMARY TABLE GLOBAL MARKET FOR CARDIOVASCULAR SURGICAL DEVICES,
THROUGH 2018 ($ MILLIONS) 8
SUMMARY FIGURE GLOBAL MARKET FOR CARDIOVASCULAR SURGICAL DEVICES,
2012 AND 2018 (%) 8

CHAPTER 3 OVERVIEW OF CARDIOVASCULAR DISEASE AND CARDIOVASCULAR
SURGERY 11


CATEGORIES OF CARDIOVASCULAR DISEASE 11
TABLE 1 LEADING CARDIOVASCULAR CONDITIONS 11
ANGINA 11
ARRHYTHMIAS 12
CARDIOMYOPATHY 12
CONGESTIVE HEART FAILURE 13
CONGENITAL HEART DISEASE 13
CORONARY ARTERY DISEASE (CAD) 14
HEART INFECTIONS 14
HYPERTENSION 14
MYOCARDIAL INFARCTION 15
VALVULAR HEART DISEASE 15
RISK FACTORS FOR CARDIOVASCULAR DISEASE 16
TABLE 2 CARDIOVASCULAR DISEASE RISK FACTORS 16
THE EVOLUTION OF CARDIOVASCULAR SURGERY 16
TABLE 3 KEY ADVANTAGES OF MINIMALLY INVASIVE CARDIAC SURGERY 17
CATEGORIES OF CARDIOVASCULAR SURGERY 18

CHAPTER 4 GLOBAL IMPLICATIONS OF CARDIOVASCULAR DISEASE AND
AVAILABILITY OF CARDIOVASCULAR SURGERY 21

INTRODUCTION 21
TABLE 4 ADULT MORTALITY FROM CARDIOVASCULAR DISEASE AND DIABETES BY
WORLD REGION, 2008 (ADULTS AGED 30–70, RATE PER 100,000 POPULATION) 22
CARDIOVASCULAR SURGERY IN THE UNITED STATES 22
HEALTHCARE SYSTEM OVERVIEW 22
TABLE 5 AMERICAN HEART ASSOCIATION DISEASE STATISTICS PREVALENCE AND
MORTALITY, CARDIOVASCULAR DISEASE, U.S., 2009 AND 2010 23
CARDIOVASCULAR SURGERY AVAILABILITY IN THE UNITED STATES 24
TABLE 6 LEADING U.S. CARDIOLOGY AND HEART SURGERY INSTITUTIONS,
2012-2013 24
U.S. MEDICAL DEVICE MARKET SIZE 24
CARDIOVASCULAR SURGERY IN EUROPE-OVERVIEW 25
TABLE 7 DEATHS FROM CARDIOVASCULAR DISEASE BY COUNTRY, EUROPE-MALES
ONLY, 2005-2010 (NO/%) 26
CARDIOVASCULAR SURGERY IN GERMANY 27
HEALTHCARE SYSTEM OVERVIEW 27
AVAILABILITY OF CARDIOVASCULAR SURGERY IN GERMANY 28
TABLE 8 LEADING GERMAN CARDIOLOGY AND HEART SURGERY INSTITUTIONS 28
CARDIOVASCULAR SURGERY IN THE UNITED KINGDOM 29
HEALTHCARE SYSTEM OVERVIEW 29
AVAILABILITY OF CARDIOVASCULAR SURGERY IN THE UNITED KINGDOM 29
TABLE 9 LEADING UNITED KINGDOM HOSPITALS OFFERING ADULT CARDIAC
SURGERY 30
CARDIOVASCULAR SURGERY IN ASIA-PACIFIC REGION-OVERVIEW 31
CARDIOVASCULAR SURGERY IN JAPAN 31
HEALTHCARE SYSTEM OVERVIEW 31
AVAILABILITY OF CARDIOVASCULAR SURGERY IN JAPAN 32
TABLE 10 LEADING JAPANESE CARDIOLOGY AND HEART SURGERY INSTITUTIONS 33
JAPANESE MEDICAL DEVICE MARKET 33
CARDIOVASCULAR SURGERY IN INDIA 33
HEALTHCARE SYSTEM OVERVIEW 33
AVAILABILITY OF CARDIOVASCULAR SURGERY IN INDIA 34
TABLE 11 LEADING INDIAN CARDIOLOGY AND HEART SURGERY INSTITUTIONS 34
INDIAN MEDICAL DEVICE MARKET 35
CARDIOVASCULAR SURGERY IN CHINA-HEALTHCARE SYSTEM OVERVIEW 36
AVAILABILITY OF CARDIOVASCULAR SURGERY IN CHINA 36
CHINESE MEDICAL DEVICE MARKET 37

CHAPTER 5 GLOBAL MARKETS FOR TRADITIONAL CARDIOVASCULAR SURGERY
DEVICES 39


DEFINITION OF TRADITIONAL CARDIOVASCULAR SURGERY 39
TABLE 12 GLOBAL MARKET FOR TRADITIONAL CARDIOVASCULAR SURGICAL
DEVICES, THROUGH 2018 ($ MILLIONS) 40
OPEN HEART SURGERY 40
CORONARY ARTERY BYPASS GRAFTING (CABG) SURGERY 40
CABG-Related Device Market Players 42
TABLE 13 PROJECTED GLOBAL MARKET FOR OPEN HEART SURGERY AND
CABG-RELATED DEVICES, THROUGH 2018 ($ MILLIONS) 42
BEATING HEART SURGERY 43
TABLE 14 PROJECTED GLOBAL MARKET FOR BEATING HEART SURGERY DEVICES,
THROUGH 2018 ($ MILLIONS) 44
OPEN HEART SURGERY FOR ATRIAL FIBRILLATION 44
TRANSMYOCARDIAL REVASCULARIZATION SURGERY 45
Transmyocardial Revascularization Device Market Players 46
TABLE 15 PROJECTED GLOBAL MARKET FOR TRANSMYOCARDIAL
REVASCULARIZATION DEVICES, THROUGH 2018 ($ MILLIONS) 47
HEART TRANSPLANT SURGERY 47
CARDIOPROSTHETIC SURGERY 47
TABLE 16 MANUFACTURERS OF CARDIOPROSTHETIC SURGERY DEVICES 48
Total Artificial Hearts 48
TABLE 17 PROJECTED GLOBAL MARKET FOR TOTAL ARTIFICIAL HEARTS, THROUGH
2018 ($ MILLIONS) 50
Ventricular Assist Devices 50
Ventricular Assist Device Market Players 52
Ventricular Assist Device Market Size 54
TABLE 18 PROJECTED GLOBAL MARKET FOR VENTRICULAR ASSIST DEVICES,
THROUGH 2018 ($ MILLIONS) 54
TABLE 19 LEADING VAD SUPPLIERS, 2012 AND 2013 ($ MILLIONS) 55
FIGURE 1 GLOBAL MARKET SHARES OF VENTRICULAR ASSIST DEVICE SUPPLIERS,
2012 (%) 55
Heart Valve Repair and Replacement 56
Heart Valve Market Players 57
Heart Valve Market Size 58
TABLE 20 PROJECTED GLOBAL MARKET FOR HEART VALVES (EXCLUDING TAVI
SYSTEMS), THROUGH 2018 ($ MILLIONS) 59
TABLE 21 LEADING HEART VALVE SUPPLIERS, 2012 ($ MILLIONS/%) 59
FIGURE 2 GLOBAL MARKET SHARES OF LEADING HEART VALVE SUPPLIERS, 2012
(%) 59
Recent Developments in the Heart Valve Market 60

CHAPTER 6 GLOBAL MARKETS FOR INTERVENTIONAL CARDIOVASCULAR SURGERY
DEVICES 62


PROCEDURE OVERVIEW 62
TABLE 22 GLOBAL MARKET FOR INTERVENTIONAL CARDIOVASCULAR SURGICAL
DEVICES, THROUGH 2018 ($ MILLIONS) 63
PCI CATHETERS AND GUIDEWIRES 63
PCI CATHETER AND GUIDEWIRE MARKET PLAYERS 64
PCI CATHETER AND GUIDEWIRE MARKET SIZE 64
TABLE 23 PROJECTED GLOBAL MARKET FOR PCI BALLOON CATHETERS AND
GUIDEWIRES, THROUGH 2018 ($ MILLIONS) 65
FIGURE 3 PCI CATHETER AND GUIDEWIRE MARKET SHARES BY SUPPLIER, 2012 (%) 65
RECENT DEVELOPMENTS IN THE PCI CATHETER AND GUIDEWIRE MARKET 66
CORONARY ARTERY STENTS 66
TABLE 24 LEADING BRANDS OF CORONARY ARTERY STENTS 68
CORONARY ARTERY STENT MARKET SIZE 68
TABLE 25 PROJECTED GLOBAL MARKET FOR CORONARY ARTERY STENTS,
THROUGH 2018 ($ MILLIONS) 69
CORONARY ARTERY STENT MARKET PLAYERS 69
FIGURE 4 GLOBAL MARKET SHARE FOR CORONARY STENT SUPPLIERS BY
COMPANY, 2012 (%) 71
FIGURE 5 GLOBAL MARKET SHARE FOR CORONARY STENT SUPPLIERS BY WORLD
REGION, 2012 (%) 72
RECENT DEVELOPMENTS IN THE CORONARY STENT MARKET 72
BALLOON VALVULOPLASTY SURGERY 74
TRANSCATHETER AORTIC VALVE INPLANTATION (TAVI) 74
TABLE 26 PROJECTED GLOBAL MARKET FOR TRANSCATHETER AORTIC VALVE
IMPLANTATION SYSTEMS, THROUGH 2018 ($ MILLIONS) 76
RENAL DENERVATION SURGERY 76
TABLE 27 PROJECTED GLOBAL MARKET FOR RENAL DENERVATION SYSTEMS,
THROUGH 2018 ($ MILLIONS) 77
USE OF ROBOTICS IN INTERVENTIONAL CARDIAC SURGERY 77
TABLE 28 PROJECTED GLOBAL MARKET FOR ROBOTIC SURGERY SYSTEMS FOR
CARDIOVASCULAR PROCEDURES, THROUGH 2018 ($ MILLIONS) 79

CHAPTER 7 GLOBAL MARKET FOR CARDIAC RHYTHM MANAGEMENT DEVICES 81

TYPES OF CARDIAC ARRHYTHMIAS 81
TABLE 29 MOST COMMON TYPES OF ARRHYTHMIAS 81
TABLE 30 GLOBAL MARKET FOR CARDIAC RHYTHM MANAGEMENT DEVICES,
THROUGH 2018 ($ MILLIONS) 82
ATRIAL FIBRILLATION 82
TREATMENTS FOR ATRIAL FIBRILLATION 83
LEFT ATRIAL APPENDAGE EXCLUSION DEVICES 83
TABLE 31 PROJECTED GLOBAL MARKET FOR LEFT ATRIAL APPENDAGE EXCLUSION
DEVICES, THROUGH 2018 ($ MILLIONS) 85
PACEMAKERS AND CRT-PS 85
PACEMAKER AND CRT-P MARKET PLAYERS 86
PACEMAKER AND CRT-P MARKET SIZE 87
TABLE 32 PROJECTED GLOBAL MARKET FOR CARDIAC PACEMAKERS AND CRT-PS,
THROUGH 2018 ($ MILLIONS) 87
FIGURE 6 GLOBAL MARKET SHARE FOR LEADING CARDIAC PACEMAKERS AND
CRT-PS SUPPLIERS, 2012 (%) 87
RECENT DEVELOPMENTS IN THE PACEMAKER MARKET 88
DEFIBRILLATORS (ICDS) AND CRT-DS 89
DEFIBRILLATOR (ICD) AND CRT-D MARKET SIZE 90
TABLE 33 PROJECTED GLOBAL MARKET FOR DEFIBRILLATORS AND CRT-DS,
THROUGH 2018 ($ MILLIONS) 90
DEFIBRILLATOR (ICD) AND CRT-D MARKET PLAYERS 90
FIGURE 7 GLOBAL MARKET SHARE FOR LEADING DEFIBRILLATOR AND CRT-D
SUPPLIERS, 2012 (%) 91
RECENT TECHNOLOGICAL ADVANCES IN DEFIBRILLATORS 92
CARDIAC LEAD REMOVAL SYSTEMS 93

CHAPTER 8 GLOBAL MARKET FOR CARDIAC ABLATION SYSTEMS AND OTHER

EMERGING THERAPIES 96
OVERVIEW OF CARDIAC ABLATION 96
CARDIAC ABLATION MARKET PLAYERS 96
CARDIAC ABLATION MARKET SIZE 97
TABLE 34 PROJECTED GLOBAL MARKET FOR CARDIAC ABLATION SYSTEMS,
THROUGH 2018 ($ MILLIONS) 97
OTHER EMERGING THERAPIES 98

CHAPTER 9 INDUSTRY CONSOLIDATION, U.S. REIMBURSEMENT CHANGES AND

TRENDS IN MEDICAL DEVICE INDUSTRY REGULATION 101
INDUSTRY CONSOLIDATION 101
TABLE 35 MAJOR ACQUISITIONS BY CARDIOVASCULAR SURGERY DEVICE
SUPPLIERS, 2008 TO 2013 102
U.S. REIMBURSEMENT CHANGES 102
TRENDS IN MEDICAL DEVICE INDUSTRY REGULATION 103
TABLE 36 RECENT FDA RECALLS OF CARDIOVASCULAR SURGERY DEVICES 104

CHAPTER 10 U.S. PATENT ANALYSIS OF CARDIOVASCULAR DEVICES 107

SUMMARY OF DEVICE PATENTS 107
TABLE 37 U.S. CARDIOVASCULAR SURGICAL DEVICE PATENTS ISSUED BY YEAR, BY
DEVICE CATEGORY, JANUARY 2011-JULY 2013 107
CARDIAC PACEMAKERS AND RELATED PRODUCTS 107
TABLE 38 U.S. CARDIAC PACEMAKER AND PACEMAKER-RELATED PATENTS,
JANUARY 2011-JULY 2013 108
IMPLANTABLE CARDIAC DEFIBRILLATORS AND RELATED DEVICES 110
TABLE 39 U.S. CARDIAC IMPLANTABLE DEFIBRILLATOR AND
DEFIBRILLATOR-RELATED PATENTS, JANUARY 2011-JULY 2013 110
CARDIAC-RELATED STENTS AND CORONARY STENTS 111
TABLE 40 U.S. CARDIAC-RELATED AND CORONARY ARTERY STENT PATENTS,
JANUARY 2011-JULY 2013 112
CARDIAC CATHETERS (INCLUDING CARDIAC ABLATION CATHETERS) 113
TABLE 41 U.S. CARDIAC CATHETER AND RELATED PATENTS, JANUARY 2011-JULY
2013 114
CARDIAC VALVES AND RELATED DEVICES 116
TABLE 42 U.S. CARDIAC VALVES AND RELATED-EQUIPMENT PATENTS, JANUARY
2011-JULY 2013 117

CHAPTER 11 COMPANY PROFILES 120

ABBOTT VASCULAR 120
BUSINESS OVERVIEW 120
PRODUCTS 120
TABLE 43 ABBOTT CARDIOVASCULAR SURGERY PRODUCTS 122
FINANCIALS 122
ABIOMED, INC. 123
BUSINESS OVERVIEW 123
PRODUCTS 123
TABLE 44 ABIOMED CARDIOVASCULAR SURGERY PRODUCTS 124
FINANCIALS 124
ATRICURE, INC. 125
BUSINESS OVERVIEW 125
PRODUCTS 125
TABLE 45 ATRICURE CARDIOVASCULAR SURGERY PRODUCTS 126
FINANCIALS 126
BIOSENSORS INTERNATIONAL 127
BUSINESS OVERVIEW 127
PRODUCTS 127
TABLE 46 BIOSENSORS INTERNATIONAL CARDIOVASCULAR SURGERY PRODUCTS 128
FINANCIAL 128
BIOTRONIK INC, DIV. BIOTRONIK SE & CO KG 128
BUSINESS OVERVIEW 129
PRODUCTS 129
TABLE 47 BIOTRONIK CARDIOVASCULAR SURGERY PRODUCTS 130
FINANCIALS 130
BIOVENTRIX, INC. 130
BUSINESS OVERVIEW 131
PRODUCT 131
FINANCIALS 131
BOSTON SCIENTIFIC CORPORATION 132
BUSINESS OVERVIEW 132
PRODUCTS 132
TABLE 48 BOSTON SCIENTIFIC CARDIOVASCULAR SURGERY PRODUCTS 133
FINANCIALS 134
C. R. BARD, INC. ELECTROPHYSIOLOGY DIVISION 135
BUSINESS OVERVIEW 135
PRODUCTS 135
TABLE 49 C. R. BARD ELECTROPHYSIOLOGY CARDIOVASCULAR SURGERY
PRODUCTS 136
FINANCIALS 136
CARDIACASSIST, INC. 136
BUSINESS OVERVIEW 136
PRODUCTS 137
TABLE 50 CARDIACASSIST CARDIOVASCULAR SURGERY PRODUCTS 137
FINANCIALS 138
CIRCULITE, INC. 138
BUSINESS OVERVIEW 138
PRODUCTS 138
FINANCIALS 139
CORDIS CORPORATION 139
BUSINESS OVERVIEW 139
PRODUCTS 140
TABLE 51 CORDIS AND BIOSENSE WEBSTER CARDIOVASCULAR SURGERY
PRODUCTS 140
FINANCIALS 140
CORINDUS VASCULAR ROBOTICS 141
BUSINESS OVERVIEW 141
PRODUCTS 141
FINANCIALS 142
CRYOLIFE INC. 142
BUSINESS OVERVIEW 142
PRODUCTS 143
TABLE 52 CRYOLIFE CARDIOVASCULAR SURGERY PRODUCTS 143
FINANCIALS 144
CVRX, INC. 144
BUSINESS OVERVIEW 144
PRODUCTS 144
FINANCIALS 145
EDWARDS LIFESCIENCES CORPORATION 145
BUSINESS OVERVIEW 145
PRODUCTS 146
TABLE 53 EDWARDS LIFESCIENCES CARDIOVASCULAR SURGERY PRODUCTS 147
FINANCIALS 147
HEARTWARE INTERNATIONAL, INC. 148
BUSINESS OVERVIEW 148
PRODUCTS 148
TABLE 54 HEARTWARE CARDIOVASCULAR SURGERY PRODUCTS 149
FINANCIALS 149
INTUITIVE SURGICAL 149
BUSINESS OVERVIEW 150
PRODUCTS 150
TABLE 55 INTUITIVE SURGICAL CARDIOVASCULAR SURGERY PRODUCTS 151
FINANCIALS 151
JARVIK HEART, INC. 151
BUSINESS OVERVIEW 152
PRODUCTS 152
TABLE 56 JARVIK HEART CARDIOVASCULAR SURGERY PRODUCT 152
FINANCIALS 152
MAQUET CARDIOVASCULAR, LLC 153
BUSINESS OVERVIEW 153
PRODUCTS 153
TABLE 57 MAQUET CARDIOVASCULAR SURGERY PRODUCTS 154
FINANCIALS 154
MEDTRONIC CORPORATION 155
BUSINESS OVERVIEW 155
PRODUCTS 155
TABLE 58 MEDTRONIC CARDIOVASCULAR SURGERY PRODUCTS 156
FINANCIALS 157
MERIT MEDICAL SYSTEMS, INC. 157
BUSINESS OVERVIEW 157
PRODUCTS 158
TABLE 59 MERIT MEDICAL CARDIOVASCULAR SURGERY PRODUCTS 159
FINANCIALS 159
MICROMED CARDIOVASCULAR INC. 159
BUSINESS OVERVIEW 159
PRODUCTS 160
TABLE 60 MICROMED CARDIOVASCULAR SURGERY PRODUCTS 160
FINANCIALS 160
ON-X LIFE TECHNOLOGIES, INC. 161
BUSINESS OVERVIEW 161
PRODUCTS 161
TABLE 61 ON-X LIFE TECHNOLOGIES CARDIOVASCULAR SURGERY PRODUCTS 162
FINANCIALS 162
ORBUSNEICH 162
BUSINESS OVERVIEW 162
PRODUCTS 163
TABLE 62 ORBUSNEICH CARDIOVASCULAR SURGERY PRODUCTS 164
FINANCIALS 164
QVANTEQ AG 164
BUSINESS OVERVIEW 164
PRODUCTS 164
FINANCIALS 165
ST. JUDE MEDICAL, INC. 165
BUSINESS OVERVIEW 165
PRODUCTS 165
TABLE 63 ST. JUDE MEDICAL CARDIOVASCULAR SURGERY PRODUCTS 167
FINANCIALS 168
SORIN GROUP SPA 168
BUSINESS OVERVIEW 168
PRODUCTS 169
TABLE 64 SORIN GROUP CARDIOVASCULAR SURGERY PRODUCTS 169
FINANCIALS 170
SPECTRANETICS CORPORATION 171
BUSINESS OVERVIEW 171
PRODUCTS 171
TABLE 65 SPECTRANETICS CARDIOVASCULAR SURGERY PRODUCTS 172
FINANCIALS 172
SUNSHINE HEART, INC. 173
BUSINESS OVERVIEW 173
PRODUCTS 173
FINANCIALS 174
SYNCARDIA SYSTEMS, INC. 174
BUSINESS OVERVIEW 174
PRODUCTS 174
TABLE 66 SYNCARDIA CARDIOVASCULAR SURGERY PRODUCTS 175
FINANCIALS 175
TERUMO CARDIOVASCULAR SYSTEMS 175
BUSINESS OVERVIEW 176
PRODUCTS 176
TABLE 67 TERUMO CARDIOVASCULAR SURGERY PRODUCTS 177
FINANCIALS 177
THORATEC CORPORATION 178
BUSINESS OVERVIEW 178
PRODUCTS 178
TABLE 68 THORATEC CARDIOVASCULAR SURGERY PRODUCTS 179
FINANCIALS 179
VOLCANO CORPORATION 180
BUSINESS OVERVIEW 180
PRODUCTS 180
TABLE 69 VOLCANO CARDIOVASCULAR SURGERY PRODUCTS 181
FINANCIALS 181

LIST OF TABLES

SUMMARY TABLE GLOBAL MARKET FOR CARDIOVASCULAR SURGICAL DEVICES,
THROUGH 2018 ($ MILLIONS) 8
TABLE 1 LEADING CARDIOVASCULAR CONDITIONS 11
TABLE 2 CARDIOVASCULAR DISEASE RISK FACTORS 16
TABLE 3 KEY ADVANTAGES OF MINIMALLY INVASIVE CARDIAC SURGERY 17
TABLE 4 ADULT MORTALITY FROM CARDIOVASCULAR DISEASE AND DIABETES BY
WORLD REGION, 2008 (ADULTS AGED 30–70, RATE PER 100,000 POPULATION) 22
TABLE 5 AMERICAN HEART ASSOCIATION DISEASE STATISTICS PREVALENCE AND
MORTALITY, CARDIOVASCULAR DISEASE, U.S., 2009 AND 2010 23
TABLE 6 LEADING U.S. CARDIOLOGY AND HEART SURGERY INSTITUTIONS,
2012-2013 24
TABLE 7 DEATHS FROM CARDIOVASCULAR DISEASE BY COUNTRY, EUROPE-MALES
ONLY, 2005-2010 (NO/%) 26
TABLE 8 LEADING GERMAN CARDIOLOGY AND HEART SURGERY INSTITUTIONS 28
TABLE 9 LEADING UNITED KINGDOM HOSPITALS OFFERING ADULT CARDIAC
SURGERY 30
TABLE 10 LEADING JAPANESE CARDIOLOGY AND HEART SURGERY INSTITUTIONS 33
TABLE 11 LEADING INDIAN CARDIOLOGY AND HEART SURGERY INSTITUTIONS 34
TABLE 12 GLOBAL MARKET FOR TRADITIONAL CARDIOVASCULAR SURGICAL
DEVICES, THROUGH 2018 ($ MILLIONS) 40
TABLE 13 PROJECTED GLOBAL MARKET FOR OPEN HEART SURGERY AND
CABG-RELATED DEVICES, THROUGH 2018 ($ MILLIONS) 42
TABLE 14 PROJECTED GLOBAL MARKET FOR BEATING HEART SURGERY DEVICES,
THROUGH 2018 ($ MILLIONS) 44
TABLE 15 PROJECTED GLOBAL MARKET FOR TRANSMYOCARDIAL
REVASCULARIZATION DEVICES, THROUGH 2018 ($ MILLIONS) 47
TABLE 16 MANUFACTURERS OF CARDIOPROSTHETIC SURGERY DEVICES 48
TABLE 17 PROJECTED GLOBAL MARKET FOR TOTAL ARTIFICIAL HEARTS, THROUGH
2018 ($ MILLIONS) 50
TABLE 18 PROJECTED GLOBAL MARKET FOR VENTRICULAR ASSIST DEVICES,
THROUGH 2018 ($ MILLIONS) 54
TABLE 19 LEADING VAD SUPPLIERS, 2012 AND 2013 ($ MILLIONS) 55
TABLE 20 PROJECTED GLOBAL MARKET FOR HEART VALVES (EXCLUDING TAVI
SYSTEMS), THROUGH 2018 ($ MILLIONS) 59
TABLE 21 LEADING HEART VALVE SUPPLIERS, 2012 ($ MILLIONS/%) 59
TABLE 22 GLOBAL MARKET FOR INTERVENTIONAL CARDIOVASCULAR SURGICAL
DEVICES, THROUGH 2018 ($ MILLIONS) 63
TABLE 23 PROJECTED GLOBAL MARKET FOR PCI BALLOON CATHETERS AND
GUIDEWIRES, THROUGH 2018 ($ MILLIONS) 65
TABLE 24 LEADING BRANDS OF CORONARY ARTERY STENTS 68
TABLE 25 PROJECTED GLOBAL MARKET FOR CORONARY ARTERY STENTS, THROUGH
2018 ($ MILLIONS) 69
TABLE 26 PROJECTED GLOBAL MARKET FOR TRANSCATHETER AORTIC VALVE
IMPLANTATION SYSTEMS, THROUGH 2018 ($ MILLIONS) 76
TABLE 27 PROJECTED GLOBAL MARKET FOR RENAL DENERVATION SYSTEMS,
THROUGH 2018 ($ MILLIONS) 77
TABLE 28 PROJECTED GLOBAL MARKET FOR ROBOTIC SURGERY SYSTEMS FOR
CARDIOVASCULAR PROCEDURES, THROUGH 2018 ($ MILLIONS) 79
TABLE 29 MOST COMMON TYPES OF ARRHYTHMIAS 81
TABLE 30 GLOBAL MARKET FOR CARDIAC RHYTHM MANAGEMENT DEVICES,
THROUGH 2018 ($ MILLIONS) 82
TABLE 31 PROJECTED GLOBAL MARKET FOR LEFT ATRIAL APPENDAGE EXCLUSION
DEVICES, THROUGH 2018 ($ MILLIONS) 85
TABLE 32 PROJECTED GLOBAL MARKET FOR CARDIAC PACEMAKERS AND CRT-PS,
THROUGH 2018 ($ MILLIONS) 87
TABLE 33 PROJECTED GLOBAL MARKET FOR DEFIBRILLATORS AND CRT-DS,
THROUGH 2018 ($ MILLIONS) 90
TABLE 34 PROJECTED GLOBAL MARKET FOR CARDIAC ABLATION SYSTEMS,
THROUGH 2018 ($ MILLIONS) 97
TABLE 35 MAJOR ACQUISITIONS BY CARDIOVASCULAR SURGERY DEVICE SUPPLIERS,
2008 TO 2013 102
TABLE 36 RECENT FDA RECALLS OF CARDIOVASCULAR SURGERY DEVICES 104
TABLE 37 U.S. CARDIOVASCULAR SURGICAL DEVICE PATENTS ISSUED BY YEAR, BY
DEVICE CATEGORY, JANUARY 2011-JULY 2013 107
TABLE 38 U.S. CARDIAC PACEMAKER AND PACEMAKER-RELATED PATENTS, JANUARY
2011-JULY 2013 108
TABLE 39 U.S. CARDIAC IMPLANTABLE DEFIBRILLATOR AND
DEFIBRILLATOR-RELATED PATENTS, JANUARY 2011-JULY 2013 110
TABLE 40 U.S. CARDIAC-RELATED AND CORONARY ARTERY STENT PATENTS,
JANUARY 2011-JULY 2013 112
TABLE 41 U.S. CARDIAC CATHETER AND RELATED PATENTS, JANUARY 2011-JULY
2013 114
TABLE 42 U.S. CARDIAC VALVES AND RELATED-EQUIPMENT PATENTS, JANUARY
2011-JULY 2013 117
TABLE 43 ABBOTT CARDIOVASCULAR SURGERY PRODUCTS 122
TABLE 44 ABIOMED CARDIOVASCULAR SURGERY PRODUCTS 124
TABLE 45 ATRICURE CARDIOVASCULAR SURGERY PRODUCTS 126
TABLE 46 BIOSENSORS INTERNATIONAL CARDIOVASCULAR SURGERY PRODUCTS 128
TABLE 47 BIOTRONIK CARDIOVASCULAR SURGERY PRODUCTS 130
TABLE 48 BOSTON SCIENTIFIC CARDIOVASCULAR SURGERY PRODUCTS 133
TABLE 49 C. R. BARD ELECTROPHYSIOLOGY CARDIOVASCULAR SURGERY PRODUCTS 136
TABLE 50 CARDIACASSIST CARDIOVASCULAR SURGERY PRODUCTS 137
TABLE 51 CORDIS AND BIOSENSE WEBSTER CARDIOVASCULAR SURGERY
PRODUCTS 140
TABLE 52 CRYOLIFE CARDIOVASCULAR SURGERY PRODUCTS 143
TABLE 53 EDWARDS LIFESCIENCES CARDIOVASCULAR SURGERY PRODUCTS 147
TABLE 54 HEARTWARE CARDIOVASCULAR SURGERY PRODUCTS 149
TABLE 55 INTUITIVE SURGICAL CARDIOVASCULAR SURGERY PRODUCTS 151
TABLE 56 JARVIK HEART CARDIOVASCULAR SURGERY PRODUCT 152
TABLE 57 MAQUET CARDIOVASCULAR SURGERY PRODUCTS 154
TABLE 58 MEDTRONIC CARDIOVASCULAR SURGERY PRODUCTS 156
TABLE 59 MERIT MEDICAL CARDIOVASCULAR SURGERY PRODUCTS 159
TABLE 60 MICROMED CARDIOVASCULAR SURGERY PRODUCTS 160
TABLE 61 ON-X LIFE TECHNOLOGIES CARDIOVASCULAR SURGERY PRODUCTS 162
TABLE 62 ORBUSNEICH CARDIOVASCULAR SURGERY PRODUCTS 164
TABLE 63 ST. JUDE MEDICAL CARDIOVASCULAR SURGERY PRODUCTS 167
TABLE 64 SORIN GROUP CARDIOVASCULAR SURGERY PRODUCTS 169
TABLE 65 SPECTRANETICS CARDIOVASCULAR SURGERY PRODUCTS 172
TABLE 66 SYNCARDIA CARDIOVASCULAR SURGERY PRODUCTS 175
TABLE 67 TERUMO CARDIOVASCULAR SURGERY PRODUCTS 177
TABLE 68 THORATEC CARDIOVASCULAR SURGERY PRODUCTS 179
TABLE 69 VOLCANO CARDIOVASCULAR SURGERY PRODUCTS 181

LIST OF FIGURES

SUMMARY FIGURE GLOBAL MARKET FOR CARDIOVASCULAR SURGICAL DEVICES,
2012 AND 2018 (%) 8
FIGURE 1 GLOBAL MARKET SHARES OF VENTRICULAR ASSIST DEVICE SUPPLIERS,
2012 (%) 55
FIGURE 2 GLOBAL MARKET SHARES OF LEADING HEART VALVE SUPPLIERS, 2012 (%) 59
FIGURE 3 PCI CATHETER AND GUIDEWIRE MARKET SHARES BY SUPPLIER, 2012 (%) 65
FIGURE 4 GLOBAL MARKET SHARE FOR CORONARY STENT SUPPLIERS BY COMPANY,
2012 (%) 71
FIGURE 5 GLOBAL MARKET SHARE FOR CORONARY STENT SUPPLIERS BY WORLD
REGION, 2012 (%) 72
FIGURE 6 GLOBAL MARKET SHARE FOR LEADING CARDIAC PACEMAKERS AND
CRT-PS SUPPLIERS, 2012 (%) 87
FIGURE 7 GLOBAL MARKET SHARE FOR LEADING DEFIBRILLATOR AND CRT-D
SUPPLIERS, 2012 (%) 91

Read the full report:
Cardiovascular Surgical Devices: Technologies and Global Markets

https://www.reportbuyer.com/product/1863184/Cardiovascular-Surgical-Devices-Technologies-and-Global-Markets.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
With major technology companies and startups seriously embracing Cloud strategies, now is the perfect time to attend @CloudExpo | @ThingsExpo, June 6-8, 2017, at the Javits Center in New York City, NY and October 31 - November 2, 2017, Santa Clara Convention Center, CA. Learn what is going on, contribute to the discussions, and ensure that your enterprise is on the right path to Digital Transformation.
Bert Loomis was a visionary. This general session will highlight how Bert Loomis and people like him inspire us to build great things with small inventions. In their general session at 19th Cloud Expo, Harold Hannon, Architect at IBM Bluemix, and Michael O'Neill, Strategic Business Development at Nvidia, discussed the accelerating pace of AI development and how IBM Cloud and NVIDIA are partnering to bring AI capabilities to "every day," on-demand. They also reviewed two "free infrastructure" pr...
DevOps and microservices are permeating software engineering teams broadly, whether these teams are in pure software shops but happen to run a business, such Uber and Airbnb, or in companies that rely heavily on software to run more traditional business, such as financial firms or high-end manufacturers. Microservices and DevOps have created software development and therefore business speed and agility benefits, but they have also created problems; specifically, they have created software securi...
Almost two-thirds of companies either have or soon will have IoT as the backbone of their business. Though, IoT is far more complex than most firms expected with a majority of IoT projects having failed. How can you not get trapped in the pitfalls? In his session at @ThingsExpo, Tony Shan, Chief IoTologist at Wipro, will introduce a holistic method of IoTification, which is the process of IoTifying the existing technology portfolios and business models to adopt and leverage IoT. He will delve in...
In the enterprise today, connected IoT devices are everywhere – both inside and outside corporate environments. The need to identify, manage, control and secure a quickly growing web of connections and outside devices is making the already challenging task of security even more important, and onerous. In his session at @ThingsExpo, Rich Boyer, CISO and Chief Architect for Security at NTT i3, will discuss new ways of thinking and the approaches needed to address the emerging challenges of securit...
As cloud adoption continues to transform business, today's global enterprises are challenged with managing a growing amount of information living outside of the data center. The rapid adoption of IoT and increasingly mobile workforce are exacerbating the problem. Ensuring secure data sharing and efficient backup poses capacity and bandwidth considerations as well as policy and regulatory compliance issues.
In his session at 20th Cloud Expo, Chris Carter, CEO of Approyo, will discuss the basic set up and solution for an SAP solution in the cloud and what it means to the viability of your company. Chris Carter is CEO of Approyo. He works with business around the globe, to assist them in their journey to the usage of Big Data in the forms of Hadoop (Cloudera and Hortonwork's) and SAP HANA. At Approyo, we support firms who are looking for knowledge to grow through current business process, where even...
The emerging Internet of Everything creates tremendous new opportunities for customer engagement and business model innovation. However, enterprises must overcome a number of critical challenges to bring these new solutions to market. In his session at @ThingsExpo, Michael Martin, CTO/CIO at nfrastructure, outlined these key challenges and recommended approaches for overcoming them to achieve speed and agility in the design, development and implementation of Internet of Everything solutions with...
One of the hottest areas in cloud right now is DRaaS and related offerings. In his session at 16th Cloud Expo, Dale Levesque, Disaster Recovery Product Manager with Windstream's Cloud and Data Center Marketing team, will discuss the benefits of the cloud model, which far outweigh the traditional approach, and how enterprises need to ensure that their needs are properly being met.
Cloud Expo, Inc. has announced today that Andi Mann and Aruna Ravichandran have been named Co-Chairs of @DevOpsSummit at Cloud Expo 2017. The @DevOpsSummit at Cloud Expo New York will take place on June 6-8, 2017, at the Javits Center in New York City, New York, and @DevOpsSummit at Cloud Expo Silicon Valley will take place Oct. 31-Nov. 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
SYS-CON Events announced today that Outlyer, a monitoring service for DevOps and operations teams, has been named “Bronze Sponsor” of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Outlyer is a monitoring service for DevOps and Operations teams running Cloud, SaaS, Microservices and IoT deployments. Designed for today's dynamic environments that need beyond cloud-scale monitoring, we make monitoring effortless so you...
It is one thing to build single industrial IoT applications, but what will it take to build the Smart Cities and truly society changing applications of the future? The technology won’t be the problem, it will be the number of parties that need to work together and be aligned in their motivation to succeed. In his Day 2 Keynote at @ThingsExpo, Henrik Kenani Dahlgren, Portfolio Marketing Manager at Ericsson, discussed how to plan to cooperate, partner, and form lasting all-star teams to change the...
@DevOpsSummit has been named the ‘Top DevOps Influencer' by iTrend. iTrend processes millions of conversations, tweets, interactions, news articles, press releases, blog posts - and extract meaning form them and analyzes mobile and desktop software platforms used to communicate, various metadata (such as geo location), and automation tools. In overall placement, @DevOpsSummit ranked as the number one ‘DevOps Influencer' followed by @CloudExpo at third, and @MicroservicesE at 24th.
What are the new priorities for the connected business? First: businesses need to think differently about the types of connections they will need to make – these span well beyond the traditional app to app into more modern forms of integration including SaaS integrations, mobile integrations, APIs, device integration and Big Data integration. It’s important these are unified together vs. doing them all piecemeal. Second, these types of connections need to be simple to design, adapt and configure...
"I think that everyone recognizes that for IoT to really realize its full potential and value that it is about creating ecosystems and marketplaces and that no single vendor is able to support what is required," explained Esmeralda Swartz, VP, Marketing Enterprise and Cloud at Ericsson, in this SYS-CON.tv interview at @ThingsExpo, held June 7-9, 2016, at the Javits Center in New York City, NY.